Bellicum Pharmaceuticals (BLCM) Q4 2022 Earnings

Mar 31Confirmed
May 2022
Aug 2022
Nov 2022
Q4 2022
-0.93
-0.66
-0.4
-0.13

Details

Expected EPS
-0.93
Actual EPS
-0.2
Surprise EPS
0.73
Surprise Percent
+78.49%

Description

⁨Bellicum Pharmaceuticals⁩ (⁦BLCM⁩) has reported earnings of ⁦-0.2⁩ per share for ⁦Q4 2022⁩.

0 Comments

Share your thoughts